SNDX
SyndaxANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
SNDX vs peer average
87/100
SNDX vs. peer average (A vs. C)
Grade spread
B 4 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CLDX is the first available peer comparator.
Celldex is a similar-cap biotech with high clinical optionality, but it lacks Syndax's commercial dual-product revenue base and is primarily a pipeline-risk reference.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SNDX
Syndax
CLDX
Celldex Therapeutics
Grade
A
D
Momentum
19
65
Value
41
41
Sentiment
93
48
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs CLDX
SNDX / CLDX
Grade Position
Above peers
SNDX vs. peer average (A vs. C)
87/100
Momentum
19
CLDXValue
41
SNDXSentiment
93
SNDXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SNDX
CLDX is the first peer returned for this comparison set.